Aurinia Pharmaceuticals Inc.
Disclosed SEC business address
#140, 14315 - 118 AVENUE, EDMONTON, A0, T5L 4S6
Aurinia Pharmaceuticals Inc. (ticker AUPH, CIK 0001600620) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: Alberta, Canada. Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 4 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-19T09:15:41.009683+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T06:36:56.824206+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T06:37:00.719118+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T06:37:04.909370+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.